DPHARMA

1.150

-0.01 (-0.9%)

Changes in Sub. S-hldr's Int (Section 138 of CA 2016)

DUOPHARMA BIOTECH BERHAD

Particulars of substantial Securities Holder

Name EMPLOYEES PROVIDENT FUND BOARD
Address 5th Floor, EPF Tower,
No.1, Persiaran Kwasa Utama,
Shah Alam
40150 Selangor
Malaysia.
Company No. EPF ACT 1991
Nationality/Country of incorporation Malaysia
Descriptions (Class) Ordinary Shares

Details of changes

No Date of change
No of securities
Type of Transaction Nature of Interest
22 Sep 2022
220,100
Disposed Direct Interest
Name of registered holder Citigroup Nominees (Tempatan) Sdn. Bhd.
Address of registered holder Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur.
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred Disposal of 220,100 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board
Nature of interest Indirect Interest
Direct (units)
Direct (%)
Indirect/deemed interest (units) 91,750,967
Indirect/deemed interest (%) 9.635
Total no of securities after change 91,750,967
Date of notice 23 Sep 2022
Date notice received by Listed Issuer 27 Sep 2022


Remarks :
Total number of Duopharma Biotech Berhad shares held are as follows:-

(a) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD: 80,470,176

(b) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (AM INV): 3,204,000

(c) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (ARIM): 811,162

(d) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (TEMPLETON): 2,127,100

(e) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (ASIANISLAMIC) IC: 67,596

(f) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (F.TEMISLAMIC) IC: 1,246,100

(g) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (CPIAM EQ) IC: 1,849,600

(h) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (NIAM EQ) IC: 1,975,233


Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 27 Sep 2022
Category Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016
Reference Number CS2-27092022-00037